NCT06958614 - Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC | Biotech Hunter

Enrollment

213

Participants

Timeline

Start Date

September 2, 2019

Primary Completion Date

November 7, 2024

Study Completion Date

January 30, 2025

Conditions

Stage II-III Non-small Cell Lung CancerConcurrent ChemotherapyConditions Influencing Health Status

Interventions

DRUG

Primary Prophylactic Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor

The experimental group received prophylactic PEG-rhG-CSF 48 hours after chemotherapy

Trial Locations (1)

Unknown

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER